Ligand validation:3A9M

HEM: PROTOPORPHYRIN IX CONTAINING FE

HEM is a Ligand Of Interest in 3A9M designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3A9M_HEM_A_153	46%	7%	0.181	0.916	2.53	2.33	10	16	4	0	100%	0.9767
2ZWJ_HEM_A_153	71%	17%	0.125	0.945	2	1.59	6	6	0	0	100%	1
3A5B_HEM_A_153	63%	7%	0.132	0.928	2.31	2.47	11	18	1	0	100%	0.9767
3ARJ_HEM_A_153	62%	11%	0.152	0.944	1.83	2.39	9	12	5	0	100%	1
3ARK_HEM_A_153	61%	11%	0.149	0.939	2.25	2	10	10	0	0	100%	1
3A5G_HEM_A_153	61%	7%	0.133	0.921	2.3	2.6	13	14	4	0	100%	0.9767
5YCE_HEM_A_201	100%	37%	0.036	0.997	1.14	1.34	2	6	1	0	100%	1
3M8M_HEM_A_396	100%	38%	0.035	0.995	1.09	1.34	3	6	0	0	100%	1
1GWE_HEM_A_504	100%	43%	0.041	0.998	0.98	1.21	1	6	0	0	100%	1
3X34_HEM_A_101	100%	28%	0.043	0.997	1.33	1.54	8	12	2	0	100%	0.8972
8IAG_HEM_B_301	100%	23%	0.04	0.992	1.7	1.5	4	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.